Exicure (XCUR) Tax Provisions (2022 - 2025)
Exicure (XCUR) reported Tax Provisions of -$634000.0 for Q4 2025, down 8025.0% quarter-over-quarter from $8000.0 in Q3 2024.
Exicure (XCUR) Tax Provisions (2022 - 2025) Analysis & Trends
Exicure has reported Tax Provisions for 3 years, with the latest figure at -$634000.0 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions changed N/A year-over-year to -$634000.0; the trailing twelve-month figure through Mar 2026 stood at -$634000.0 (down 8025.0% YoY), and the FY2025 full-year result was -$634000.0, down 8025.0% from the prior year.
- Tax Provisions for Q4 2025 stood at -$634000.0, down from $8000.0 in the prior quarter.
- The five-year high for Tax Provisions was $209000.0 in Q4 2022, with the low at -$634000.0 in Q4 2025.
- Historically, Tax Provisions has averaged -$139000.0 across 3 years, with a median of $8000.0 in 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Exicure | 18.48 Mn | 15.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -634,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Dec 31, 2022 | 209,000.00 |